Abstract
MALDI imaging for metabolites and immunohistochemistry for 38 immune markers was used to characterize the spatial biology of 2 primary oral tumours, one from a patient with an early recurrence (Tumour R), and the other from a patient with no recurrence 2 years after treatment completion (Tumour NR). Tumour R had an increased purine nucleotide metabolism in different regions of tumour and adenosine-mediated suppression of immune cells compared to Tumour NR. The differentially expressed markers in the different spatial locations in tumour R were CD33, CD163, TGF-β, COX2, PD-L1, CD8 and CD20. These results suggest that altered tumour metabolomics concomitant with a modified immune microenvironment could be a potential marker of recurrence.
Similar content being viewed by others
Data availability
All data has been provided in the manuscript. However if additional information is required will be shared on reasonable request to the corresponding author.
References
Hu Y, Zhong R, Li H, Zou Y (2020) Effects of betel quid, smoking and alcohol on oral cancer risk: a case-control study in Hunan Province, China. Subst Use Misuse 55:1501–1508. https://doi.org/10.1080/10826084.2020.1750031
Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31–46. https://doi.org/10.1158/2159-8290.CD-21-1059
Martínez-Reyes I, Chandel NS (2021) Cancer metabolism: looking forward. Nat Rev Cancer 21:669–680. https://doi.org/10.1038/s41568-021-00378-6
Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Cancer Res 79:4557–4566. https://doi.org/10.1158/0008-5472.CAN-18-3962
Annaratone L, Cascardi E, Vissio E et al (2020) The multifaceted nature of tumor microenvironment in breast carcinomas. Pathobiology 87:125–142. https://doi.org/10.1159/000507055
Sistigu A, Musella M, Galassi C, Vitale I, De Maria R (2020) Tuning cancer fate: tumor microenvironment’s role in cancer stem cell quiescence and reawakening. Front Immunol 11:2166. https://doi.org/10.3389/fimmu.2020.02166
Leone RD, Powell JD (2020) Metabolism of immune cells in cancer. Nat Rev Cancer 20:516–531. https://doi.org/10.1038/s41568-020-0273-y
Bayik D, Lathia JD (2021) Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer 21:526–536. https://doi.org/10.1038/s41568-021-00366-w
Wang ZH, Peng WB, Zhang P, Yang XP, Zhou Q (2021) Lactate in the tumour microenvironment: From immune modulation to therapy. EBioMedicine 73:103627. https://doi.org/10.1016/j.ebiom.2021.103627
Puccetti P, Fallarino F (2022) T cell fat catabolism: a novel target for kynurenine? EBioMedicine 75:103779. https://doi.org/10.1016/j.ebiom.2021.103779
Mukherjee G, Bag S, Chakraborty P et al (2020) Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival. PLoS ONE 15:e0242058. https://doi.org/10.1371/journal.pone.0242058
Hendry S, Salgado R, Gevaert T et al (2017) Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology biomarkers working group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv Anat Pathol 24:235–251. https://doi.org/10.1097/PAP.0000000000000162
Hendry S, Salgado R, Gevaert T et al (2017) Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immuno-oncology biomarkers working group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors. Adv Anat Pathol 24:311–335. https://doi.org/10.1097/PAP.0000000000000161
Deininger SO, Cornett DS, Paape R et al (2011) Normalization in MALDI-TOF imaging datasets of proteins: practical considerations. Anal Bioanal Chem 401:167–181. https://doi.org/10.1007/s00216-011-4929-z
Leone RD, Emens LA (2018) Targeting adenosine for cancer immunotherapy. J Immunother Cancer 6:57. https://doi.org/10.1186/s40425-018-0360-8
Semenza GL (2021) Intratumoral hypoxia and mechanisms of immune evasion mediated by hypoxia-inducible factors. Physiology (Bethesda) 36:73–83. https://doi.org/10.1152/physiol.00034.2020
Chaudhary A, Bag S, Arora N et al (2020) Hypoxic transformation of immune cell metabolism within the microenvironment of oral cancers. Front Oral Health 1:585710. https://doi.org/10.3389/froh.2020.585710
Yadollahi P, Jeon YK, Ng WL et al (2021) Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity. BMB Rep 54:12–20. https://doi.org/10.5483/BMBRep.2021.54.1.241
DiLillo DJ, Yanaba K, Tedder TF (2010) B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol 184:4006–4016. https://doi.org/10.4049/jimmunol.0903009
Nielsen JS, Sahota RA, Milne K et al (2012) CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res 18:3281–3292. https://doi.org/10.1158/1078-0432.CCR-12-0234
Svensson MC, Warfvinge CF, Fristedt R et al (2017) The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma. Oncotarget 8:72108–72126. https://doi.org/10.18632/oncotarget.19437
Pagès F, Berger A, Camus M et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353:2654–2666. https://doi.org/10.1056/NEJMoa051424
Simonetti G, Mengucci C, Padella A et al (2021) Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations. Leukemia 35:2813–2826. https://doi.org/10.1038/s41375-021-01318-x
Ohradanova-Repic A, Machacek C, Charvet C et al (2018) Extracellular purine metabolism is the switchboard of immunosuppressive macrophages and a novel target to treat diseases with macrophage imbalances. Front Immunol 9:852. https://doi.org/10.3389/fimmu.2018.00852
Xu F, Wei Y, Tang Z et al (2020) Tumor-associated macrophages in lung cancer: friend or foe? (review). Mol Med Rep 22:4107–4115. https://doi.org/10.3892/mmr.2020.11518
Alexandrov T, Becker M, Deininger SO et al (2010) Spatial segmentation of imaging mass spectrometry data with edge-preserving image denoising and clustering. J Proteome Res 9:6535–6546. https://doi.org/10.1021/pr100734z
Chan MK, Chung JY, Tang PC et al (2022) TGF-β signaling networks in the tumor microenvironment. Cancer Lett 550:215925. https://doi.org/10.1016/j.canlet.2022.215925
Li S, Jiang M, Wang L et al (2020) Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement. Biomed Pharmacother 129:110389. https://doi.org/10.1016/j.biopha.2020.110389
Coy S, Wang S, Stopka SA et al (2022) Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun 13:4814. https://doi.org/10.1038/s41467-022-32430-w
Acknowledgements
We are grateful to M/S Bruker, Germany, for running the experiments of MALDI.
Funding
GM acknowledges the Department of Biotechnology, Government of India, New Delhi, for funding under the Systems Medicine Cluster (SyMeC, Project Reference: No./BT/Med-II/NIBMG/SyMeC/2014/Vol II).
Author information
Authors and Affiliations
Contributions
Research planning: GM, SB; Conduct and reporting: GM, JO, SB; Conception and design: GM; Acquisition and interpretation of data: JO, SB, AC, SS; Clinical study: GM, PA; Manuscript preparation: GM, SB, SS.
Corresponding author
Ethics declarations
Competing interest
JO is employed at Bruker Daltonics GmbH Co. KG, a vendor for mass spectrometers. All other authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bag, S., Oetjen, J., Shaikh, S. et al. Impact of spatial metabolomics on immune-microenvironment in oral cancer prognosis: a clinical report. Mol Cell Biochem 479, 41–49 (2024). https://doi.org/10.1007/s11010-023-04713-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-023-04713-3